Moderna, Inc. (NASDAQ:MRNA) Receives $58.70 Consensus Target Price from Brokerages
Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have been given an average recommendation of “Hold” by the twenty-four research firms that are covering the company, Marketbeat.com reports. Four analysts have rated the stock with a sell recommendation, sixteen have issued a hold recommendation, three have issued a buy recommendation and one has given […]
Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have been given an average recommendation of “Hold” by the twenty-four research firms that are covering the company, Marketbeat.com reports. Four analysts have rated the stock with a sell recommendation, sixteen have issued a hold recommendation, three have issued a buy recommendation and one has given […]
